TOBRADEX Ophthalmic suspension (2020)
Βιβλιογραφική αναφορά
Συγγραφείς
Alcon Laboratories, Inc.
Για την προβολή της πλήρους καταχώρησης απαιτείται συνδρομή σε ισχύ.
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
Αποκτήστε πρόσβαση σε όλες τις πληροφορίες και τα εργαλεία του Galinos.gr δωρεάν για έναν μήνα απλά κάνοντας εγγραφή.
Δωρεάν εγγραφή
1. Description
TOBRADEX (tobramycin and dexamethasone ophthalmic suspension) is a sterile, multiple dose antibiotic and steroid combination for topical ophthalmic use. The chemical structures for tobramycin and dexamethasone ...
2. Clinical Pharmacology
Corticoids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Since corticoids may inhibit the bodys defense mechanism against infection, a concomitant antimicrobial ...
3. Indications and Usage
TOBRADEX (tobramycin and dexamethasone ophthalmic suspension) is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ...
4. Contraindications
Epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and many other viral diseases of the cornea and conjunctiva. Mycobacterial infection of the eye. Fungal diseases of ocular ...
5. Warnings
FOR TOPICAL OPHTHALMIC USE. <b>NOT FOR INJECTION INTO THE EYE.</b> Sensitivity to topically applied aminoglycosides may occur in some patients. Severity of hypersensitivity reactions may vary from local ...
6.1. General
The possibility of fungal infections of the cornea should be considered after long-term steroid dosing. As with other antibiotic preparations, prolonged use may result in overgrowth of nonsusceptible organisms, ...
6.2. Information for Patients
Do not touch dropper tip to any surface, as this may contaminate the contents. Contact lenses should not be worn during the use of this product.
6.6. Carcinogenesis, Mutagenesis, Impairment of Fertility
No studies have been conducted to evaluate the carcinogenic or mutagenic potential. No impairment of fertility was noted in studies of subcutaneous tobramycin in rats at doses of 50 and 100 mg/kg/day. ...
6.7. Pregnancy
Corticosteroids have been found to be teratogenic in animal studies. Ocular administration of 0.1% dexamethasone resulted in 15.6% and 32.3% incidence of fetal anomalies in two groups of pregnant rabbits. ...
6.9. Nursing Mothers
Systemically administered corticosteroids appear in human milk and could suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. It is not known whether topical ...
6.10. Pediatric Use
Safety and effectiveness in pediatric patients below the age of 2 years have not been established.
6.11. Geriatric Use
No overall differences in safety or effectiveness have been observed between elderly and younger patients.
7. Adverse Reactions
Adverse reactions have occurred with steroid/anti-infective combination drugs which can be attributed to the steroid component, the anti-infective component, or the combination. Exact incidence figures ...
10. Dosage and Administration
One or two drops instilled into the conjunctival sac(s) every four to six hours. During the initial 24 to 48 hours, the dosage may be increased to one or two drops every two (2) hours. Frequency should ...
11. How Supplied
Sterile ophthalmic suspension in 2.5 mL (NDC 0065-0647-25), 5 mL (NDC 0065-0647-05) and 10 mL (NDC 0065-0647-10) dispensers. Distributed by: Novartis Pharmaceuticals Corporation, East Hanover, New Jersey ...
12. Storage and Handling
Store at 8°C to 27°C (46°F to 80°F). Store suspension upright and shake well before using. After opening, TOBRADEX (tobramycin and dexamethasone ophthalmic suspension) can be used until the expiration ...